Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home ETF

Is Physical Gold the Ultimate Hedge? VanEck Merk Gold Trust Offers Unique Exposure

Robert Sasse by Robert Sasse
August 19, 2025
in ETF
0
VanEck Merk Gold Trust Stock
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

As global uncertainty persists, investors continue turning to gold as a strategic store of value. The VanEck Merk Gold Trust (NYSE: OUNZ) stands out among precious metal ETFs by offering something rare—direct conversion to physical bullion.

Gold’s Market Dynamics

The yellow metal currently trades near $3,350 per ounce, consolidating after last year’s impressive rally. Three key drivers support gold prices:

  1. Escalating geopolitical tensions, particularly surrounding the Ukraine conflict
  2. Anticipated Federal Reserve rate cuts (85% probability priced in for September)
  3. Record central bank demand across emerging and developed markets

A Distinctive ETF Structure

Unlike conventional gold funds, OUNZ provides tangible asset ownership:

  • Each share represents precisely 481,682 ounces of gold (as of August 15)
  • Bullion stored under strict custody at JPMorgan Chase vaults
  • Exclusive physical redemption feature for shareholders

This pure-play approach eliminates sector concentration risks and country-specific exposures common in equity ETFs.

Should investors sell immediately? Or is it worth buying VanEck Merk Gold Trust?

Performance Metrics Reveal Strength

Recent returns demonstrate gold’s resilience:

  • Short-term dips: -1.77% (weekly) / -0.28% (monthly)
  • Strong quarterly gains: +4.52% (3 months)
  • Year-to-date surge: +25.96%
  • Annual outperformance: +33.93%

Liquidity remains robust with 797,067 shares traded daily (20-day average). The fund tracks the LBMA Gold Price PM benchmark with near-perfect precision, maintaining just 0.01% NAV deviation.

Competitive Landscape

While established players like SPDR Gold Shares (GLD) and iShares Gold Trust (IAU) dominate the space, OUNZ carves its niche through physical convertibility—a game-changer for investors seeking actual metal ownership rather than paper claims.

The fund’s unique redemption mechanism addresses a critical investor need: the ability to transform digital holdings into tangible wealth during market stress. As monetary policies shift and global risks multiply, this physical access feature may grow increasingly valuable.

Ad

VanEck Merk Gold Trust Stock: Buy or Sell?! New VanEck Merk Gold Trust Analysis from February 7 delivers the answer:

The latest VanEck Merk Gold Trust figures speak for themselves: Urgent action needed for VanEck Merk Gold Trust investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

VanEck Merk Gold Trust: Buy or sell? Read more here...

Tags: VanEck Merk Gold Trust
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Ishares Msci Acwi ETF Stock
Analysis

Global ETF Investors Await Crucial Index Reshuffle

February 6, 2026
iShares Global Clean Energy ETF Stock
AI & Quantum Computing

The AI Power Surge: Reshaping the Clean Energy Investment Thesis

February 4, 2026
iShares MSCI EAFE ETF Stock
Asian Markets

iShares MAFE ETF Reaches Fresh 52-Week Peak

February 3, 2026
Next Post
Johnson & Johnson Stock

Johnson & Johnson Shares Gain Momentum on Strong Earnings and Medical Breakthroughs

Unitedhealth Stock

Warren Buffett Bets Big on Troubled Healthcare Giant UnitedHealth

Livent Stock

Rio Tinto's Lithium Power Play: How a $6.7B Acquisition Reshapes the Battery Materials Race

Recommended

Super Micro Computer Stock

Super Micro Stock Surges Amid AI Infrastructure Boom

4 months ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

4 months ago
IBM Stock

Strong IBM Earnings Fail to Impress Market as Key Segment Shows Weakness

4 months ago
Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Trending

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

by Rodolfo Hanigan
February 7, 2026
0

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business...

CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes
  • Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com